Current Neuro-Oncology

Volume 9 Number 2
28 February 2007

Home > Publications > Current Neuro-Oncology > Volume 9, Year 2007 > Number 2, 28 February

Park DM, Li J, Okamoto H, Akeju O, Kim SH, Lubensky I, Vortmeyer A, Dambrosia J, Weil RJ, Oldfield EH, Park JK, Zhuang Z.
N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation.
Cell Cycle. 2007 Feb 12. 2007;6(4):467-70. doi: 10.4161/cc.6.4.3856⍈. PMID: 17312396⍈. Laboratory investigation. ⍈

Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Dowell JM, Reardon DA, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Wagner M, Bigner DD, Friedman AH, Friedman HS.
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.
Clin Cancer Res. 2007 Feb 15;13(4):1253-9⍈. doi: 10.1158/1078-0432.CCR-06-2309⍈. PMID: 17317837⍈. Phase 2 trial. ⍈